Somewhere around 33 million Americans use sleep apnea devices to help them get a better night sleep, but new data shows they ...

We can talk all day about the Apple Watch Series 10 and its new off-angle viewing screen, sleep apnea abilities, Training ...

FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and drug label updates.

According to the FDA, Apple’s Sleep Apnea Notification Feature is not intended to diagnose, treat, or aid in the management of sleep apnea.

Scans were taken starting three weeks before conception, through nine months of pregnancy and then two years postpartum. The study documented a widespread decrease in the volume of gray matter that ...

It’s the age of personal health technology—from apps to wearable devices, we’re surrounded by tools designed to help us stay ...

The gross proceeds to the Company from the offering are expected to be approximately $4.3 million, before deducting the placement agent's fees and other offering expenses payable by the Company. The ...

This shift towards patient-centered innovation is necessary. We're living in an aging society, where the needs of older ...

The S&P 500 ended 0.3% lower on Wednesday, Sept. 18, 2024, as the Federal Reserve announced its first interest-rate cut since ...

In the release announcing its Watch Series 10’s availability, Apple refers to the device’s “refined” design. It’s an accurate ...

Vivos Therapeutics is a pioneering medical device and technology company focused on addressing sleep-related breathing disorders (SRBDs), particularly obstructive sleep apnea (OSA). Their flagship ...

Vivos Therapeutics (VVOS) stock gains as company receives FDA clearance for its DNA appliance to treat obstructive sleep ...